Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Phase III results positive for memantine in AD

Feb. 25, 2000

NK1 receptor antagonist CP-99994 tested in ferret model of emesis

Feb. 25, 2000

FDA issues approvable letter for Pharmacia & Upjohn's Vestra

Feb. 24, 2000

Nastech's NDA for intranasal scopolamine not accepted for filing

Feb. 24, 2000

AMPA antagonists improve neurological outcome in EAE

Feb. 24, 2000

Pregabalin now claimed for renal colic-associated pain

Feb. 24, 2000

New study contradicts earlier indications of efficacy for ERT in treating Alzheimer's disease

Feb. 24, 2000

YM-872 exerts neuroprotective effects in rat transient MCA occlusion model

Feb. 24, 2000

New antiepileptic Diastat available in Canada for ARS

Feb. 23, 2000

Early clinical trial in Japan demonstrates safety, favorable pharmacokinetics of CGS-19755

Feb. 23, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.